Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 6.93% vs 9.42% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 5.14% vs 1,630.97% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 52.17% vs 7.27% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -9.20% vs -12.54% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Amgen, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -12.55% vs 3.24% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 6.93% vs 9.42% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 36.46% vs -58.55% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.14% vs 1,630.97% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -24.75% vs 31.42% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 52.17% vs 7.27% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 2.76% vs -6.45% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -9.20% vs -12.54% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






